Recently, in triple-negative breast cancer cells MDA-MB-321, its activity was related to the decrease in CD44, CD24, Bcl2, release of Cytochrome c to the cytoplasm, and mitochondrial reduction [49]. This evidence concerns the gene BCL2 and triple-negative breast carcinoma.